Caregivers' attitudes toward blood-based biomarker testing for Alzheimer's disease.
Katharina BolsewigHester BlokEline A J WillemseRob B M Groot ZwaaftinkMinke KooistraEllen M A SmetsCharlotte E TeunissenLeonie N C VisserPublished in: Alzheimer's & dementia (Amsterdam, Netherlands) (2024)
Most informal caregivers would want blood-based biomarker (BBBM) testing for Alzheimer's disease (AD) diagnosis.Perceived (dis)advantages were related to diagnosing AD early.With severe symptoms, there was less confidence in normal BBBM results.Treatment availability would significantly increase interest in BBBM testing for AD.Informal caregivers showed uncertainty regarding the meaning of the term "AD."